Focusing on rare conditions could reduce kidney disease burden

Focusing on rare conditions could significantly reduce the burden of kidney disease on both patients and the NHS, according to a major new study led by UCL and the UK Kidney Association.

Biolinq Secures $58M to Advance Continuous Glucose Monitoring Patch

What You Should Know: – Biolinq, a provider of precision wearable biosensors for metabolic health secures $58M led by Alpha Wave Ventures. The round will

April 4, 2024

Risk Adjusted Net Present Value: What is the current valuation of Ultragenyx Pharmaceutical’s Rebisufligene Etisparvovec

The revenue for Rebisufligene Etisparvovec is expected to reach an annual total of $102 mn by 2038 globally based off GlobalData’s Expiry Model. The drug’s

May 16, 2024

RSV vaccines may be linked to small increased risk of developing Guillain-Barré syndrome, data suggest

The new vaccines that protect older adults against respiratory syncytial virus, or RSV, may be linked to a small increased risk of developing Guillain-Barré syndrome,

February 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.